(2S,5R,7R,10R,11S,15S)-2,7,10,11-tetrahydrogenio-5-hydroxy-15-methyl-5-(2-(trimethylsilyl)ethynyl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one
|
|
(2S,5R,7R,10R,11S,15S)-2,7,10,11-tetrahydrogenio-5-hydroxy-15-methyl-5-(2-(trimethylsilyl)ethynyl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one Eigenschaften
Sicherheit
(2S,5R,7R,10R,11S,15S)-2,7,10,11-tetrahydrogenio-5-hydroxy-15-methyl-5-(2-(trimethylsilyl)ethynyl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one Chemische Eigenschaften,Einsatz,Produktion Methoden
(2S,5R,7R,10R,11S,15S)-2,7,10,11-tetrahydrogenio-5-hydroxy-15-methyl-5-(2-(trimethylsilyl)ethynyl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(2S,5R,7R,10R,11S,15S)-2,7,10,11-tetrahydrogenio-5-hydroxy-15-methyl-5-(2-(trimethylsilyl)ethynyl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 1)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Pharmalego | 13472578225 18321033991 |
marketing@pharmalego.com | China | 2964 | 58 |
- (2S,5R,7R,10R,11S,15S)-2,7,10,11-tetrahydrogenio-5-hydroxy-15-methyl-5-(2-(trimethylsilyl)ethynyl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one